Influx Healthtech IPO sees strong demand; booked 3x on Day 1, GMP at 47%

Influx Healthtech IPO Day 1 subscription status: The SME offering received bids for 1,24,32,000 shares against the issue size of 43,64,400

Influx Healthtech Day 1 subscription status: The initial public offering (IPO) of healthcare-focused contract manufacturing company Influx Healthtech received a solid response from investors as the issue was fully subscribed on the first day of bidding.

 

As of 2:30 PM, the SME offering received bids for 1,42,23,600 shares against the issue size of 43,64,400, resulting in an oversubscription of 3.3 times, according to National Stock Exchange (NSE) data.

 

The issue opened for public subscription today, June 18, 2025, and will close on Friday, June 20, 2025.

Influx Healthtech IPO grey market premium (GMP)

The unlisted shares of Influx Healthtech were trading at ₹141 in the grey market, commanding a premium of ₹45 or 47 per cent compared to the upper price band of ₹96, according to sources tracking unofficial markets. 

Influx Healthtech IPO details

The company aims to raise ₹55.63 crore through a combination of a fresh issue of 4.69 million equity shares amounting to 45.07 crore and an offer for sale (OFS) of 1.1 million shares amounting to ₹10.56 crore. Munir Abdul Ganee Chandniwala is the promoter-selling shareholder. 

 

Once the bidding is closed, the basis of allotment of Influx Healthtech shares is expected to be finalised on Monday, June 23. The company is scheduled to make its debut on the NSE SME platform on Wednesday, June 25.   Influx Healthtech has set the price band in the range of ₹91 to ₹96. The lot size has been fixed at 1,200 shares.

 

Maashitla Securities is the registrar of the issue. Rarever Financial Advisors is the sole book-running lead manager.

Influx Healthtech IPO objective

According to the red herring prospectus (RHP), the company intends to use the net fresh issue proceeds for the set up of the manufacturing facility Nutraceutical Division, a manufacturing facility for the Veterinary Food Division; purchase of machinery for Homecare and Cosmetic Division, and general corporate purposes.  

About Influx Healthtech

Incorporated in 2020, Mumbai-based Influx Healthtech is a healthcare-focused company specialising in contract 

manufacturing. It operates a manufacturing facility located in Thane, Maharashtra. The company produces Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, care products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables.